Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Biol Chem. 2007 Aug 10;282(32):23129-39. Epub 2007 Jun 1.

Activation of inhibitors by sortase triggers irreversible modification of the active site.

Author information

  • 1Department of Microbiology, University of Chicago, Chicago, Illinois 60637, USA.

Abstract

Sortases anchor surface proteins to the cell wall of Gram-positive pathogens through recognition of specific motif sequences. Loss of sortase leads to large reductions in virulence, which identifies sortase as a target for the development of antibacterials. By screening 135,625 small molecules for inhibition, we report here that aryl (beta-amino)ethyl ketones inhibit sortase enzymes from staphylococci and bacilli. Inhibition of sortases occurs through an irreversible, covalent modification of their active site cysteine. Sortases specifically activate this class of molecules via beta-elimination, generating a reactive olefin intermediate that covalently modifies the cysteine thiol. Analysis of the three-dimensional structure of Bacillus anthracis sortase B with and without inhibitor provides insights into the mechanism of inhibition and reveals binding pockets that can be exploited for drug discovery.

PMID:
17545669
[PubMed - indexed for MEDLINE]
PMCID:
PMC3366505
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk